UPDATE : Wednesday, June 19, 2019
상단여백
Alteogen promote antibody-drug conjugate cancer treatment in US by Lee Han-soo 2018-11-14 16:59
GCAM opens new plasma collection centers in US by Lee Han-soo 2018-11-09 17:58
GC launches Biocon’s antidiabetic biosimilar by Lee Han-soo 2018-11-08 15:46
'Biosimilar makers to benefit from new research accounting guideline' by Nam Doo-hyun 2018-11-07 11:23
Biois seeks KOSDAQ listing with ‘technology exception policy’ by So Jae-hyeon 2018-11-06 15:43
라인
Market caps of top 20 drugmakers on KOSPI surged this year by Nam Doo-hyun 2018-11-06 15:41
Samsung BioLogics to complete Biogen’s call option by Lee Han-soo 2018-11-06 10:45
Will PharmAbcine be new force on KOSDAQ? by Nam Doo-hyun 2018-11-05 16:32
Celltrion gets orders for Herzuma in France by Lee Han-soo 2018-11-02 17:08
Government to help Pharmicell develop therapy for acute kidney injury by Lee Han-soo 2018-11-02 14:16
라인
SLS Bio registers patent for nanotechnology multiplex diagnostic in Europe by Lee Han-soo 2018-11-01 11:03
CrystalGenomics to change molecular targeted therapy from injection to oral drug in trials by Nam Doo-hyun 2018-10-30 10:52
‘I will help make Korea original holder of anticancer drugs’ by So Jae-hyeon 2018-10-29 14:43
‘Bio Solution’s value to rise on arthritis cell therapy’ by Nam Doo-hyun 2018-10-25 16:30
Samsung BioLogics posts ₩101.1 billion in Q3 sales by Lee Han-soo 2018-10-25 11:02
라인
CancerRop advances into Malaysian gene market by Lee Han-soo 2018-10-24 17:49
Celltrion releases clinical trial results for Remsima SC in EU and US by Lee Han-soo 2018-10-24 16:47
Will synthetic biology be vital in smart therapeutics? by Nam Doo-hyun 2018-10-24 16:40
Biotech shares tank amid nosediving of Seoul stocks by Nam Doo-hyun 2018-10-24 11:35
‘Antibody drug developer AbClon noteworthy’ by Nam Doo-hyun 2018-10-22 14:49
여백
여백
여백
Back to Top